Share Price and Basic Stock Data
Last Updated: January 19, 2026, 9:25 pm
| PEG Ratio | 9.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Marico Ltd operates in the edible oils and solvent extraction industry, with a market capitalization of ₹97,324 Cr and a current share price of ₹750. The company’s revenue from operations demonstrated a steady upward trend, recording ₹9,764 Cr for the fiscal year ending March 2023, up from ₹9,512 Cr in March 2022. For FY 2025, revenue is projected to rise to ₹10,831 Cr, while the trailing twelve months (TTM) revenue stands at ₹12,265 Cr. Quarterly sales figures show fluctuations, with the highest sales in Sep 2025 at ₹3,482 Cr. This trend indicates a potential recovery and growth trajectory post-pandemic, supported by the company’s strong market presence and brand equity. The company’s operational performance is complemented by an operating profit margin (OPM) of 20% for FY 2025, suggesting efficient cost management in a competitive sector.
Profitability and Efficiency Metrics
Marico Ltd’s profitability metrics reflect a robust operational framework, with a reported net profit of ₹1,696 Cr for the latest fiscal year. The company’s return on equity (ROE) stands at an impressive 41.3%, indicating effective utilization of shareholders’ funds. The operating profit margin has shown resilience, with FY 2025 reporting a margin of 20%. However, the net profit margin slightly declined to 15.3% in FY 2025 from 15.55% in FY 2024, indicating potential pressure on profitability. The interest coverage ratio (ICR) is notably high at 44.28x, showcasing the company’s ability to meet interest obligations comfortably. Additionally, the cash conversion cycle (CCC) is reported at 33 days, reflecting efficient management of working capital. These metrics position Marico favorably against typical sector averages, suggesting a solid operational base.
Balance Sheet Strength and Financial Ratios
Marico’s balance sheet exhibits considerable strength, with total assets reported at ₹8,281 Cr as of March 2025. The company’s reserves increased to ₹3,922 Cr, highlighting a strong retained earnings position. With borrowings at ₹575 Cr, the total debt-to-equity ratio remains low at 0.09, indicating a prudent capital structure and low financial risk. The company has a current ratio of 2.07, suggesting ample liquidity to cover short-term liabilities. Furthermore, the price-to-book value ratio stands at 21.15x, which is relatively high, indicating market confidence but also reflecting the premium investors place on its earnings growth potential. Marico’s return on capital employed (ROCE) of 45.2% underscores effective capital utilization, which is significantly above industry averages, reflecting operational efficiency.
Shareholding Pattern and Investor Confidence
Marico’s shareholding pattern reveals significant institutional and promoter ownership, with promoters holding 58.94% of the equity, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 24.21% and 11.88%, respectively. This distribution indicates a strong level of confidence among institutional investors in Marico’s long-term prospects. However, there has been a gradual decline in promoter shareholding from 59.48% in Dec 2022 to the current level, which may raise concerns about long-term strategic control. The total number of shareholders has decreased to 289,152, suggesting potential consolidation among investors. Despite these shifts, the high promoter and institutional ownership reflects a solid base of support, contributing to investor confidence in the company’s future performance.
Outlook, Risks, and Final Insight
Marico Ltd’s outlook appears positive, driven by its strong financial performance and operational efficiency. The company’s capacity to generate robust profits and maintain high ROE positions it well for future growth. However, risks remain, including potential volatility in raw material prices and changes in consumer preferences, which could impact margins. Additionally, the slight decline in net profit margins could signal underlying challenges in maintaining profitability amidst rising costs. In a scenario where the company can successfully navigate these risks, it may continue to expand its market share and enhance shareholder value. Conversely, failure to manage these challenges could hinder growth, necessitating a strategic reassessment. Overall, Marico’s strong fundamentals provide a solid foundation for future growth, contingent upon effective risk management strategies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 451 Cr. | 347 | 610/320 | 12.4 | 107 | 0.00 % | 18.7 % | 29.2 % | 10.0 |
| IEL Ltd | 101 Cr. | 7.76 | 10.3/4.00 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 308 Cr. | 1.64 | 3.58/1.52 | 215 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 63.0 Cr. | 2.64 | 3.95/1.45 | 24.5 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,872 Cr. | 1,384 | 3,633/321 | 1,907 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 9,651.13 Cr | 169.49 | 147.39 | 37.26 | 0.18% | 14.31% | 12.90% | 4.29 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,496 | 2,470 | 2,240 | 2,477 | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,259 | 3,482 |
| Expenses | 2,063 | 2,014 | 1,847 | 1,903 | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,604 | 2,922 |
| Operating Profit | 433 | 456 | 393 | 574 | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 |
| OPM % | 17% | 18% | 18% | 23% | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% |
| Other Income | 19 | 40 | 68 | 46 | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 |
| Interest | 15 | 14 | 17 | 17 | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 |
| Depreciation | 37 | 39 | 43 | 36 | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 |
| Profit before tax | 400 | 443 | 401 | 567 | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 |
| Tax % | 23% | 25% | 24% | 23% | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% |
| Net Profit | 307 | 333 | 305 | 436 | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 |
| EPS in Rs | 2.33 | 2.54 | 2.34 | 3.30 | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 |
Last Updated: December 30, 2025, 1:06 am
Below is a detailed analysis of the quarterly data for Marico Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,482.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,259.00 Cr. (Jun 2025) to 3,482.00 Cr., marking an increase of 223.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,922.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,604.00 Cr. (Jun 2025) to 2,922.00 Cr., marking an increase of 318.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 560.00 Cr.. The value appears to be declining and may need further review. It has decreased from 655.00 Cr. (Jun 2025) to 560.00 Cr., marking a decrease of 95.00 Cr..
- For OPM %, as of Sep 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Jun 2025) to 16.00%, marking a decrease of 4.00%.
- For Other Income, as of Sep 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Jun 2025) to 49.00 Cr., marking a decrease of 7.00 Cr..
- For Interest, as of Sep 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Jun 2025) to 12.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 47.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 45.00 Cr. (Jun 2025) to 47.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 550.00 Cr.. The value appears to be declining and may need further review. It has decreased from 656.00 Cr. (Jun 2025) to 550.00 Cr., marking a decrease of 106.00 Cr..
- For Tax %, as of Sep 2025, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Jun 2025) to 21.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 513.00 Cr. (Jun 2025) to 432.00 Cr., marking a decrease of 81.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.24. The value appears to be declining and may need further review. It has decreased from 3.89 (Jun 2025) to 3.24, marking a decrease of 0.65.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,687 | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 12,265 |
| Expenses | 3,939 | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 10,059 |
| Operating Profit | 748 | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,206 |
| OPM % | 16% | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 18% |
| Other Income | 58 | 59 | 93 | 96 | 85 | 103 | 95 | 107 | 98 | 144 | 142 | 208 | 194 |
| Interest | 34 | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 47 |
| Depreciation | 77 | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 188 |
| Profit before tax | 695 | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,165 |
| Tax % | 27% | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | |
| Net Profit | 504 | 585 | 723 | 811 | 827 | 1,131 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,696 |
| EPS in Rs | 3.76 | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 12.86 |
| Dividend Payout % | 46% | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.07% | 23.59% | 12.17% | 1.97% | 36.76% | -7.78% | 14.96% | 4.67% | 5.34% | 13.62% | 10.39% |
| Change in YoY Net Profit Growth (%) | 0.00% | 7.52% | -11.42% | -10.20% | 34.79% | -44.54% | 22.74% | -10.29% | 0.67% | 8.28% | -3.23% |
Marico Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 10, 2025, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 |
| Reserves | 1,296 | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 | 3,922 |
| Borrowings | 680 | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 | 575 |
| Other Liabilities | 925 | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,752 | 4,052 |
| Total Liabilities | 2,965 | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 | 8,679 |
| Fixed Assets | 888 | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 | 2,791 |
| CWIP | 4 | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 | 52 |
| Investments | 311 | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 | 1,394 |
| Other Assets | 1,762 | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,893 | 4,442 |
| Total Assets | 2,965 | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 | 8,679 |
Below is a detailed analysis of the balance sheet data for Marico Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,846.00 Cr. (Mar 2025) to 3,922.00 Cr., marking an increase of 76.00 Cr..
- For Borrowings, as of Sep 2025, the value is 575.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 554.00 Cr. (Mar 2025) to 575.00 Cr., marking an increase of 21.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,052.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,752.00 Cr. (Mar 2025) to 4,052.00 Cr., marking an increase of 300.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 8,679.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,281.00 Cr. (Mar 2025) to 8,679.00 Cr., marking an increase of 398.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,791.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,758.00 Cr. (Mar 2025) to 2,791.00 Cr., marking an increase of 33.00 Cr..
- For CWIP, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 1,394.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,590.00 Cr. (Mar 2025) to 1,394.00 Cr., marking a decrease of 196.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,442.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,893.00 Cr. (Mar 2025) to 4,442.00 Cr., marking an increase of 549.00 Cr..
- For Total Assets, as of Sep 2025, the value is 8,679.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,281.00 Cr. (Mar 2025) to 8,679.00 Cr., marking an increase of 398.00 Cr..
Notably, the Reserves (3,922.00 Cr.) exceed the Borrowings (575.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 442.00 | -330.00 | -238.00 | -311.00 | -351.00 | -337.00 | -510.00 | -478.00 | -607.00 | -526.00 | -552.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 |
| Inventory Days | 151 | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 |
| Days Payable | 95 | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 |
| Cash Conversion Cycle | 73 | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 |
| Working Capital Days | -13 | 18 | 0 | 23 | 37 | 27 | 24 | -11 | 5 | 2 | 14 | 16 |
| ROCE % | 29% | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 27,125,016 | 2.11 | 1945.95 | 26,497,061 | 2025-12-14 00:38:48 | 2.37% |
| Franklin India Flexi Cap Fund | 4,800,948 | 1.72 | 344.42 | 4,100,000 | 2025-12-08 01:29:31 | 17.1% |
| Sundaram Mid Cap Fund | 3,660,354 | 1.97 | 262.59 | N/A | N/A | N/A |
| UTI Flexi Cap Fund | 3,624,000 | 1.02 | 259.99 | 5,101,646 | 2025-12-08 01:29:31 | -28.96% |
| Edelweiss Mid Cap Fund | 3,377,095 | 1.84 | 242.27 | N/A | N/A | N/A |
| Tata Arbitrage Fund | 2,901,600 | 1.03 | 208.16 | 2,550,000 | 2025-12-13 06:39:15 | 13.79% |
| Franklin India Mid Cap Fund | 1,800,000 | 1 | 129.13 | N/A | N/A | N/A |
| Franklin India ELSS Tax Saver Fund | 1,733,734 | 1.83 | 124.38 | 1,800,000 | 2025-12-08 01:29:31 | -3.68% |
| ICICI Prudential Equity & Debt Fund | 1,662,697 | 0.24 | 119.28 | N/A | N/A | N/A |
| Sundaram Large and Mid Cap Fund | 1,650,000 | 1.68 | 118.37 | 1,700,000 | 2025-12-15 02:05:39 | -2.94% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.59 | 11.46 | 10.08 | 9.50 | 9.08 |
| Diluted EPS (Rs.) | 12.56 | 11.43 | 10.05 | 9.49 | 9.08 |
| Cash EPS (Rs.) | 14.23 | 12.87 | 11.45 | 10.81 | 10.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.81 | 32.32 | 30.67 | 26.40 | 25.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.81 | 32.32 | 30.67 | 26.40 | 25.26 |
| Revenue From Operations / Share (Rs.) | 83.96 | 74.83 | 75.69 | 73.74 | 62.39 |
| PBDIT / Share (Rs.) | 18.19 | 16.81 | 15.15 | 13.79 | 13.06 |
| PBIT / Share (Rs.) | 16.81 | 15.58 | 13.95 | 12.71 | 11.98 |
| PBT / Share (Rs.) | 16.40 | 15.02 | 13.51 | 12.41 | 11.82 |
| Net Profit / Share (Rs.) | 12.85 | 11.64 | 10.25 | 9.73 | 9.31 |
| NP After MI And SOA / Share (Rs.) | 12.63 | 11.48 | 10.09 | 9.50 | 9.09 |
| PBDIT Margin (%) | 21.66 | 22.45 | 20.01 | 18.70 | 20.93 |
| PBIT Margin (%) | 20.02 | 20.82 | 18.42 | 17.24 | 19.20 |
| PBT Margin (%) | 19.53 | 20.06 | 17.85 | 16.83 | 18.94 |
| Net Profit Margin (%) | 15.30 | 15.55 | 13.53 | 13.19 | 14.92 |
| NP After MI And SOA Margin (%) | 15.04 | 15.34 | 13.33 | 12.87 | 14.56 |
| Return on Networth / Equity (%) | 40.99 | 38.64 | 34.27 | 36.58 | 36.17 |
| Return on Capital Employeed (%) | 36.90 | 40.38 | 39.82 | 45.14 | 44.20 |
| Return On Assets (%) | 19.53 | 19.95 | 18.74 | 21.17 | 21.27 |
| Total Debt / Equity (X) | 0.09 | 0.09 | 0.12 | 0.10 | 0.10 |
| Asset Turnover Ratio (%) | 1.37 | 1.34 | 1.53 | 1.50 | 1.34 |
| Current Ratio (X) | 2.07 | 1.64 | 1.57 | 1.63 | 1.66 |
| Quick Ratio (X) | 1.56 | 1.09 | 1.07 | 0.97 | 1.10 |
| Inventory Turnover Ratio (X) | 8.43 | 3.08 | 3.53 | 3.94 | 2.98 |
| Dividend Payout Ratio (NP) (%) | 27.80 | 82.98 | 44.70 | 97.55 | 82.59 |
| Dividend Payout Ratio (CP) (%) | 25.06 | 74.98 | 39.94 | 87.60 | 73.83 |
| Earning Retention Ratio (%) | 72.20 | 17.02 | 55.30 | 2.45 | 17.41 |
| Cash Earning Retention Ratio (%) | 74.94 | 25.02 | 60.06 | 12.40 | 26.17 |
| Interest Coverage Ratio (X) | 44.28 | 29.70 | 34.89 | 45.62 | 49.56 |
| Interest Coverage Ratio (Post Tax) (X) | 32.28 | 21.58 | 24.61 | 33.18 | 35.94 |
| Enterprise Value (Cr.) | 83930.05 | 63877.10 | 61757.30 | 64793.85 | 52505.50 |
| EV / Net Operating Revenue (X) | 7.75 | 6.62 | 6.33 | 6.81 | 6.52 |
| EV / EBITDA (X) | 35.76 | 29.46 | 31.61 | 36.42 | 31.16 |
| MarketCap / Net Operating Revenue (X) | 7.76 | 6.64 | 6.34 | 6.83 | 6.60 |
| Retention Ratios (%) | 72.19 | 17.01 | 55.29 | 2.44 | 17.40 |
| Price / BV (X) | 21.15 | 16.73 | 16.29 | 19.41 | 16.38 |
| Price / Net Operating Revenue (X) | 7.76 | 6.64 | 6.34 | 6.83 | 6.60 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
After reviewing the key financial ratios for Marico Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.59. This value is within the healthy range. It has increased from 11.46 (Mar 24) to 12.59, marking an increase of 1.13.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.56. This value is within the healthy range. It has increased from 11.43 (Mar 24) to 12.56, marking an increase of 1.13.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.23. This value is within the healthy range. It has increased from 12.87 (Mar 24) to 14.23, marking an increase of 1.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.81. It has decreased from 32.32 (Mar 24) to 30.81, marking a decrease of 1.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.81. It has decreased from 32.32 (Mar 24) to 30.81, marking a decrease of 1.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.96. It has increased from 74.83 (Mar 24) to 83.96, marking an increase of 9.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.19. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.19, marking an increase of 1.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.81. This value is within the healthy range. It has increased from 15.58 (Mar 24) to 16.81, marking an increase of 1.23.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.40. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 16.40, marking an increase of 1.38.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.85. This value is within the healthy range. It has increased from 11.64 (Mar 24) to 12.85, marking an increase of 1.21.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.63. This value is within the healthy range. It has increased from 11.48 (Mar 24) to 12.63, marking an increase of 1.15.
- For PBDIT Margin (%), as of Mar 25, the value is 21.66. This value is within the healthy range. It has decreased from 22.45 (Mar 24) to 21.66, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 20.02. This value exceeds the healthy maximum of 20. It has decreased from 20.82 (Mar 24) to 20.02, marking a decrease of 0.80.
- For PBT Margin (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 20.06 (Mar 24) to 19.53, marking a decrease of 0.53.
- For Net Profit Margin (%), as of Mar 25, the value is 15.30. This value exceeds the healthy maximum of 10. It has decreased from 15.55 (Mar 24) to 15.30, marking a decrease of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has decreased from 15.34 (Mar 24) to 15.04, marking a decrease of 0.30.
- For Return on Networth / Equity (%), as of Mar 25, the value is 40.99. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 40.99, marking an increase of 2.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 36.90. This value is within the healthy range. It has decreased from 40.38 (Mar 24) to 36.90, marking a decrease of 3.48.
- For Return On Assets (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 19.95 (Mar 24) to 19.53, marking a decrease of 0.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.37. It has increased from 1.34 (Mar 24) to 1.37, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has increased from 1.64 (Mar 24) to 2.07, marking an increase of 0.43.
- For Quick Ratio (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 1.56, marking an increase of 0.47.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.43. This value exceeds the healthy maximum of 8. It has increased from 3.08 (Mar 24) to 8.43, marking an increase of 5.35.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 27.80. This value is within the healthy range. It has decreased from 82.98 (Mar 24) to 27.80, marking a decrease of 55.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 25.06. This value is within the healthy range. It has decreased from 74.98 (Mar 24) to 25.06, marking a decrease of 49.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 72.20. This value exceeds the healthy maximum of 70. It has increased from 17.02 (Mar 24) to 72.20, marking an increase of 55.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 74.94. This value exceeds the healthy maximum of 70. It has increased from 25.02 (Mar 24) to 74.94, marking an increase of 49.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 44.28. This value is within the healthy range. It has increased from 29.70 (Mar 24) to 44.28, marking an increase of 14.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.28. This value is within the healthy range. It has increased from 21.58 (Mar 24) to 32.28, marking an increase of 10.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 83,930.05. It has increased from 63,877.10 (Mar 24) to 83,930.05, marking an increase of 20,052.95.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.75. This value exceeds the healthy maximum of 3. It has increased from 6.62 (Mar 24) to 7.75, marking an increase of 1.13.
- For EV / EBITDA (X), as of Mar 25, the value is 35.76. This value exceeds the healthy maximum of 15. It has increased from 29.46 (Mar 24) to 35.76, marking an increase of 6.30.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 7.76, marking an increase of 1.12.
- For Retention Ratios (%), as of Mar 25, the value is 72.19. This value exceeds the healthy maximum of 70. It has increased from 17.01 (Mar 24) to 72.19, marking an increase of 55.18.
- For Price / BV (X), as of Mar 25, the value is 21.15. This value exceeds the healthy maximum of 3. It has increased from 16.73 (Mar 24) to 21.15, marking an increase of 4.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 7.76, marking an increase of 1.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Marico Ltd:
- Net Profit Margin: 15.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 36.9% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 40.99% (Industry Average ROE: 12.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.28
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 59.3 (Industry average Stock P/E: 147.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.09
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 7th Floor, Grande Palladium, 175, CST Road, Mumbai Maharashtra 400098 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harsh Mariwala | Chairman & Non-Exe.Director |
| Mr. Saugata Gupta | Managing Director & CEO |
| Mr. Nikhil Khattau | Non Executive Director |
| Mr. Rishabh Mariwala | Non Executive Director |
| Mr. Rajendra Mariwala | Non Executive Director |
| Mr. Milind Barve | Lead Independent Director |
| Mr. Ananth Sankaranarayanan | Independent Director |
| Mr. Rajeev Vasudeva | Independent Director |
| Ms. Apurva Purohit | Independent Director |
| Ms. Nayantara Bali | Independent Director |
| Mr. Rajan Bharti Mittal | Independent Director |
FAQ
What is the intrinsic value of Marico Ltd?
Marico Ltd's intrinsic value (as of 20 January 2026) is ₹658.70 which is 13.44% lower the current market price of ₹761.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹98,791 Cr. market cap, FY2025-2026 high/low of ₹780/578, reserves of ₹3,922 Cr, and liabilities of ₹8,679 Cr.
What is the Market Cap of Marico Ltd?
The Market Cap of Marico Ltd is 98,791 Cr..
What is the current Stock Price of Marico Ltd as on 20 January 2026?
The current stock price of Marico Ltd as on 20 January 2026 is ₹761.
What is the High / Low of Marico Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Marico Ltd stocks is ₹780/578.
What is the Stock P/E of Marico Ltd?
The Stock P/E of Marico Ltd is 59.3.
What is the Book Value of Marico Ltd?
The Book Value of Marico Ltd is 31.2.
What is the Dividend Yield of Marico Ltd?
The Dividend Yield of Marico Ltd is 1.38 %.
What is the ROCE of Marico Ltd?
The ROCE of Marico Ltd is 45.2 %.
What is the ROE of Marico Ltd?
The ROE of Marico Ltd is 41.3 %.
What is the Face Value of Marico Ltd?
The Face Value of Marico Ltd is 1.00.